Use Bronchoscopy to Predict Post-Extubation Stridor in Critical Ill Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
Our study aims at the accuracy of bronchoscopy to predict PES. Evidence base medicine guidelines for extubation may be obtained through this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 14, 2009
CompletedFirst Posted
Study publicly available on registry
January 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJanuary 16, 2009
January 1, 2009
3 years
January 14, 2009
January 15, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The accuracy of bronchoscopy to predict post-extubation stridor.
48 hours
Interventions
The patients in our ICU intubated for \> 24h and met weaning criteria, will be examined by bronchoscopy. Five ㏄ blood will be collected for checking CRP and cytokines before performing bronchoscopy. The proposed grading of post-extubation vocal cord finding were shown (Figure 1). The patients will be classified to two groups (Figure 2). The first group is these patients without swelling or swelling area ≦50% who will be extubated after bronchoscopic examination. These patients will be followed for 48 hours to monitor the incidence of PES. The second group is those patients who develop laryngeal edema with swelling area ≧50% or swelling in the whole vocal cord. Bosmin 2 ml local injection and Solu-medrol 40 mg I.V. Q6h for 1\~4 days will be given. Bronchoscopy will be done if CLV ≧24% or after treatments for 3\~4 days even with CLV \<24%. The above treatments will be applied again if stridor develops. Extubation will be performed if no presence of laryngeal edema.
Eligibility Criteria
You may qualify if:
- Age equal or greater than 18 years old
- Intubation over 24 hrs
- Match weaning profile
- Cuff leak volume less than 24%
- VS and subject/family agree
You may not qualify if:
- Re-Intubation
- History of upper air way obstruction
- Severe CV disease (ex. AMI)
- Active UGI Bleeding
- Blood sugar persistent more than 250 mg/dl under medication control
- Risk of IICP
- Open T.B.
- Bleeding tendency/ Platelet less than 40 thousands
- Subject or family refuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Intensive Care Medicine; Chi Mei Medical Center
Tainan, 710, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 14, 2009
First Posted
January 16, 2009
Study Start
December 1, 2006
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
January 16, 2009
Record last verified: 2009-01